↓ Skip to main content

PLOS

Direct Angiotensin II Type 2 Receptor Stimulation Ameliorates Insulin Resistance in Type 2 Diabetes Mice with PPARγ Activation

Overview of attention for article published in PLOS ONE, November 2012
Altmetric Badge

Mentioned by

twitter
1 X user
patent
2 patents

Citations

dimensions_citation
65 Dimensions

Readers on

mendeley
34 Mendeley
citeulike
1 CiteULike
Title
Direct Angiotensin II Type 2 Receptor Stimulation Ameliorates Insulin Resistance in Type 2 Diabetes Mice with PPARγ Activation
Published in
PLOS ONE, November 2012
DOI 10.1371/journal.pone.0048387
Pubmed ID
Authors

Kousei Ohshima, Masaki Mogi, Fei Jing, Jun Iwanami, Kana Tsukuda, Li-Juan Min, Akiyoshi Ogimoto, Björn Dahlöf, Ulrike M. Steckelings, Tomas Unger, Jitsuo Higaki, Masatsugu Horiuchi

Abstract

The role of angiotensin II type 2 (AT(2)) receptor stimulation in the pathogenesis of insulin resistance is still unclear. Therefore we examined the possibility that direct AT(2) receptor stimulation by compound 21 (C21) might contribute to possible insulin-sensitizing/anti-diabetic effects in type 2 diabetes (T2DM) with PPARγ activation, mainly focusing on adipose tissue.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 3%
Unknown 33 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 18%
Student > Master 5 15%
Researcher 4 12%
Student > Bachelor 3 9%
Student > Doctoral Student 2 6%
Other 7 21%
Unknown 7 21%
Readers by discipline Count As %
Medicine and Dentistry 8 24%
Agricultural and Biological Sciences 8 24%
Biochemistry, Genetics and Molecular Biology 4 12%
Unspecified 2 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 4 12%
Unknown 7 21%